WallStreetZenWallStreetZen

NASDAQ: CGTX
Cognition Therapeutics Inc Stock Ownership - Who owns Cognition Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cognition Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Aaron Gl FletcherDirector2025-09-197,729$0.84
$6.49kBuy
Anthony CaggianoChief Medical Officer2025-07-2920,281$0.67
$13.59kSell
Lisa RicciardiCEO President2025-07-2923,400$0.67
$15.68kSell
John Brendan DoyleChief Financial Officer2025-07-299,360$0.67
$6.27kSell
John Brendan DoyleChief Financial Officer2025-05-019,692$0.45
$4.33kSell
John Brendan DoyleChief Financial Officer2025-02-151,723$0.59
$1.02kSell
Anthony CaggianoChief Medical Officer2025-02-155,296$0.59
$3.12kSell
Lisa RicciardiCEO President2025-02-156,619$0.59
$3.91kSell
Anthony CaggianoChief Medical Officer2025-02-0312,779$0.67
$8.51kSell
Lisa RicciardiCEO President2025-02-0328,960$0.67
$19.29kSell

1 of 2

CGTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CGTX insiders and whales buy or sell their stock.

CGTX Shareholders

What type of owners hold Cognition Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aaron Gl Fletcher13.99%10,276,947$16.24MInsider
Leslie W. Kreis8.65%6,356,377$10.04MInsider
Bios Capital Management LP8.17%6,000,000$9.48MInstitution
Bios Memory Spv I LP5.33%3,912,841$6.18MInsider
Ogden Cap Associates LLC3.01%2,210,377$3.49MInsider
Vanguard Group Inc1.78%1,304,350$2.06MInstitution
Lisa Ricciardi1.33%977,517$1.54MInsider
Acadian Asset Management LLC0.96%701,940$1.11MInstitution
Chescapmanager LLC0.68%503,259$795.15kInstitution
Bios Clinical Opportunity Fund LP0.68%500,095$790.15kInsider

1 of 3

CGTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CGTX15.27%35.09%Net SellingNet Buying
AGEN6.36%93.64%Net BuyingNet Buying
HURA12.72%37.74%
TVGN2.46%84.32%Net Selling
IRD5.32%94.68%Net BuyingNet Buying
View Top Biotech Stocks

Cognition Therapeutics Stock Ownership FAQ

Who owns Cognition Therapeutics?

Cognition Therapeutics (NASDAQ: CGTX) is owned by 15.27% institutional shareholders, 35.09% Cognition Therapeutics insiders, and 49.63% retail investors. Aaron Gl Fletcher is the largest individual Cognition Therapeutics shareholder, owning 10.28M shares representing 13.99% of the company. Aaron Gl Fletcher's Cognition Therapeutics shares are currently valued at $16.96M.

If you're new to stock investing, here's how to buy Cognition Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.